drugset
drugset / Trial / NCT03720717

Baclofen as a Perioperative Analgesic Adjuvant

NCT03720717 ↗

Phase 4 Terminated 34 enrolled University of Alabama at Birmingham
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether a single, oral dose of baclofen alters postoperative opioid requirements.

Timeline

Start
2020-10-27
Primary completion
2022-10-28
Completion
2022-10-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Baclofen Small molecule 10 mg Oral

Indications

No indication recorded.